Otriven Protect Für Erwachsene Und Kinder Ab 12 Jahren (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline hydrochloride, the active ingredient in Otriven Protect Für Erwachsene Und Kinder Ab 12 Jahren, is an Alpha‑2‑adrenergic agonist presented as a nasal spray for topical use. It relieves nasal congestion in adults and children aged 12 years and older. GNH USA supplies Otriven Protect Für Erwachsene Und Kinder Ab 12 Jahren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Otriven Protect contains xylometazoline, an alpha‑2‑adrenergic agonist that acts on nasal mucosal vessels to reduce congestion. - Common cold nasal congestion: provides temporary relief of blocked nose symptoms. - Allergic rhinitis: helps alleviate nasal blockage associated with seasonal allergies. - Sinusitis-related congestion: reduces swelling of nasal passages during acute sinus inflammation.

Adverse reactions are generally mild and related to local nasal irritation.

Common Side Effects: - Nasal burning or stinging sensation. - Mild dryness of the nasal mucosa. - Sneezing shortly after application. - Transient headache. - Runny nose after initial use.

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration. - Severe headache or facial pain. - Signs of allergic reaction such as rash, itching or swelling. - Nasal bleeding that does not stop with gentle pressure.

Before using Otriven Protect, consider the following safety measures: - Age restriction: not for children under 12 years. - Duration of use: limit to 3‑5 days to avoid rebound congestion. - Pre‑existing nasal conditions: use with caution in chronic rhinitis or nasal polyps. - Concomitant nasal sprays: avoid simultaneous use of other decongestant sprays. - Pregnancy and lactation: consult a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medications that affect nasal blood flow or blood pressure.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may enhance vasoconstrictive effects. - Systemic alpha‑adrenergic agonists: combined use can increase blood pressure.

Moderate Interactions (Monitor Closely): - Nasal corticosteroids: monitor for increased local irritation. - Antihistamines: may potentiate drying of nasal mucosa. - Antihypertensive drugs: observe for any unexpected changes in blood pressure.